Have a personal or library account? Click to login
Huntington’s Australia – a New National Association to Support the Huntington’s Community Cover

Huntington’s Australia – a New National Association to Support the Huntington’s Community

Open Access
|May 2023

References

  1. Ghosh R, Tabrizi SJ. (2018). Clinical Features of Huntington’s Disease. Adv Exp Med Biol., 1049:1-28. Doi: 10.1007/978-3-319-71779-1_1. PMID: 29427096.
  2. Harper PS. (1991). Huntington’s Disease. Major Problems in Neurology 22, London, WB Saunders Company Ltd. p.3.
  3. Hayden MR. (1981). Huntington’s Chorea. Berlin, Heidelberg, Springer-Verlag. Chapter 5, p.59.
  4. McColgan P, Tabrizi SJ. (2018). Huntington’s disease: a clinical review. Eur J Neurol. Jan;25(1):24-34. Doi: 10.1111/ene.13413. Epub 2017 Sep 22. PMID: 28817209.
  5. Medina A, Mahjoub Y, Shaver L, Pringsheim T. (2022). Prevalence and Incidence of Huntington’s Disease: An Updated Systematic Review and Meta-Analysis. Mov Disord. Dec;37(12):2327-2335. Doi: 10.1002/mds.29228. Epub 2022 Sep 26. PMID: 36161673.
  6. Piña-Aguilar RE, Simpson SA, Alshatti A, Clarke A, Craufurd D, Dorkins H, Doye K, Lahiri N, Lashwood A, Lynch C, Miller C, Morton S, O’Driscoll M, Quarrell OW, Rae D, Strong M, Tomlinson C, Turnpenny P, Miedzybrodzka Z; UK HD Predictive Testing Consortium. (2019). 27 years of prenatal diagnosis for Huntington disease in the United Kingdom. Genet Med. Jul;21(7):1639-1643. Doi: 10.1038/s41436-018-0367-z. Epub 2018 Dec 14. PMID: 30546084.
  7. Rawlins MD, Wexler NS, Wexler AR, Tabrizi SJ, Douglas I, Evans SJ, Smeeth L. (2016). The Prevalence of Huntington’s Disease. Neuroepidemiology. 46(2):144-53. doi: 10.1159/000443738. Epub 2016 Jan 30. PMID: 26824438.
  8. Quaid KA. (2017). Genetic testing for Huntington disease. Handb Clin Neurol. 144:113-126. doi: 10.1016/B978-0-12-801893-4.00010-9. PMID: 28947110.
  9. Samperi SV, Kwong P, McGill T. (2021). Huntington’s disease: A Nursing Perspective. AJON. 31(2), 18-26. Doi:10.21307/ajon-2021 -007
  10. Sathe S, Ware J, Levey J, Neacy E, Blumenstein R, Noble S, Mühlbäck A, Rosser A, Landwehrmeyer GB, Sampaio C. (2021). Enroll-HD: An Integrated Clinical Research Platform and Worldwide Observational Study for Huntington’s Disease. Front Neurol. Aug 18;12:667420. doi: 10.3389/fneur.2021.667420. PMID: 34484094; PMCID: PMC8416308.
  11. Tabrizi SJ, Estevez-Fraga C, van Roon-Mom WMC, Flower MD, Scahill RI, Wild EJ, MuñozSanjuan I, Sampaio C, Rosser AE, Leavitt BR. (2022). Potential disease-modifying therapies for Huntington’s disease: lessons learned and future opportunities. Lancet Neurol. Jul;21(7):645-658. doi: 10.1016/S1474-4422(22)00121-1. PMID: 35716694; PMCID: PMC7613206.
  12. The Huntington’s Disease Collaborative Research Group. (1993). A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington’s disease chromosomes. Cell. Mar 26;72(6):971-83. doi: 10.1016/0092-8674(93)90585-e. PMID: 8458085
DOI: https://doi.org/10.21307/ajon-2023-010 | Journal eISSN: 2208-6781 | Journal ISSN: 1032-335X
Language: English
Page range: 79 - 85
Published on: May 30, 2023
Published by: Australasian Neuroscience Nurses Association
In partnership with: Paradigm Publishing Services
Publication frequency: 2 issues per year

© 2023 Elizabeth Thompson, Christopher Glasson, published by Australasian Neuroscience Nurses Association
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.